Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Unichem Laboratories Ltd. Capital/Financing Update 2023

Feb 6, 2023

61109_rns_2023-02-06_f4f4e399-0961-465c-8163-f2f42619063a.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [190 x 43] intentionally omitted <==

Date: 6[th] February 2023

Department of Corporate Services . National Stock Exchange of India Limited Bombay Stock Exchange, Exchange Plaza Phiroze Jeejeebhoy Towers, Bandra Kurla Complex Dalal Street, Bandra (East) Mumbai – 400 001 Mumbai- 400 051 Script Code : 506690 Symbol : UNICHEMLAB

Dear Sir/Madam,

Sub.: Extension of the exercise period for the options granted and vested under Unichem

Employee Stock Option Scheme 2018.

Pursuant to Regulation 30 of SEBI Listing Regulations, 2015 and further to our letter dated August 7, 2018 filed with the exchanges, we wish to inform you that pursuant to the powers conferred under the duly approved Unichem Employee Stock Option Scheme 2018 of the Company (" Scheme ”), the Nomination and Remuneration Committee (“NRC”) of the Board of Directors of the Company at its meeting held on February 6, 2023, have extended the exercise period of the first tranche of vested options held by the option holders under the Scheme. Rest of the terms and conditions of the options so granted remain unchanged.

Total Options Granted as disclosed under the Letter: 15,12,224 options have been granted by the NRC in terms of the Scheme. None of these options have been exercised till date.

Tranche of
Options
Vesting Date Current Exercise
period
Extended Exercise
Period
50% of the Options
Granted
1stApril 2022 Within 15 months from
the vesting date (Upto
30THJune 2023)
The
Current
exercise
period is extended by
additional 12 months Upto
30thJune 2024)
Balance 50% of
the Option Granted
1stApril 2023 Within 15 months from
the vesting date Upto
30THJune 2024)
No change

The Company has received In Principle Listing Approval for the shares arising out of exercise of options under the Scheme, from BSE Limited and NSE Limited.

Please take the above on record.

Thanking you, For UNICHEM LABORATORIES LIMITED

PRADEEP Digitally signed by PRADEEP BHANDARI BHANDARI Date: 2023.02.06 13:33:54 +05'30' PRADEEP BHANDARI Head- Legal & Company Secretary

==> picture [189 x 31] intentionally omitted <==

Registered Office: Unichem Bhavan, Prabhat Estate, Off S. V. Road Jogeshwari (West), Mumbai – 400 102, Maharashtra, India.